期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 23, 期 6, 页码 3795-3807出版社
WILEY
DOI: 10.1111/jcmm.14330
关键词
cardiac hypertrophy; heart failure; post-translational modifications (PTMs)
资金
- Natural Science Foundation of Shandong Province [ZR2017BC003]
- National Natural Science Foundation of China [31701175]
- China Postdoctoral Science Foundation [2017M612188]
Pathological cardiac hypertrophy involves excessive protein synthesis, increased cardiac myocyte size and ultimately the development of heart failure. Thus, pathological cardiac hypertrophy is a major risk factor for many cardiovascular diseases and death in humans. Extensive research in the last decade has revealed that post-translational modifications (PTMs), including phosphorylation, ubiquitination, SUMOylation, O-GlcNAcylation, methylation and acetylation, play important roles in pathological cardiac hypertrophy pathways. These PTMs potently mediate myocardial hypertrophy responses via the interaction, stability, degradation, cellular translocation and activation of receptors, adaptors and signal transduction events. These changes occur in response to pathological hypertrophy stimuli. In this review, we summarize the roles of PTMs in regulating the development of pathological cardiac hypertrophy. Furthermore, PTMs are discussed as potential targets for treating or preventing cardiac hypertrophy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据